The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Measles | Polio | Vaccine
World leaders made historic commitments to provide equal access to vaccines for all
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
FDA cleared IND application to enable phase II trial of ViralClear’s merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
Moderna announced positive interim phase 1 data for mRNA Vaccine against novel Coronavirus
On May 18, 2020, Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus…
NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
Research from University of Washington demonstrated high performance of Abbott’s SARS-CoV-2 antibody blood test
On May 8, 2020, Abbott announced new research, published in the Journal of Clinical Microbiology, which found that…